Trisodium 2-methylcitrate serves as an endogenous metabolite in the 2-methylcitric acid cycle and acts as a metabolic biomarker in methylmalonic acidemia and malonic acidemia; it significantly inhibits ADP-stimulated and uncoupled respiration supported by glutamate in mitochondria; it impairs glutamate metabolism and induces mitochondrial permeability transition in brain mitochondria; it inhibits glutamate dehydrogenase (GDH) activity at concentrations as low as 0.5 mM; it acts as a potent inhibitor of glutamate oxidation by suppressing GDH activity and functions as an inducer of mitochondrial permeability transition, thereby disrupting mitochondrial energy homeostasis.